TransMedics Group, Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
8.8
Very Bullish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
TMDX
Earnings growing 1188% year-over-year on 32% revenue growth.
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $156.00 (+56.0%)
10 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
TMDX
UNH
20.5×
Trailing P/E
27.9×
27.2×
Forward P/E
17.8×
31.4%
Profit Margin
2.7%
59.9%
Gross Margin
18.8%
54.2%
ROE
12.2%
32.2%
Revenue Growth
2.0%
1188.1%
Earnings Growth
0.7%
2.08
Beta
0.41
—
Price / Book
—
$3.5B
Market Cap
$334.9B
$90 – $156
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →